Company page

Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc. is a public company listed under the ticker TSHA, operating in the American market. The company has a market capitalization of approximately $1.84 billion. Taysha focuses on developing gene therapies for neurological diseases, aiming to address unmet medical needs in this area.